Off patent drug possibility for Covid. Ursodeo... - CLL Support

CLL Support

22,529 members38,700 posts

Off patent drug possibility for Covid. Ursodeoxycholic acid (UDCA), an approved liver disease drug, reduces ACE2 levels on lab-grown cells

Eucalyptus22 profile image
1 Reply

There seems to be a deal of excitement in certain media areas about research involving UK, European and US researchers on a covid treatment drug. The one in question is an off patent drug ursodeoxycholic acid currently used to treat liver damage so a re-purposing rather than development of a new drug. There is also mention of a roll-out to a bigger trial within the UK.

nature.com/articles/s41586-...

medscape.com/viewarticle/98...

Certainly for us more vulnerable patients this might be a life saver especially as it is already available and doesn't have to go through the normal NICE channels in the UK.

Maybe a glimmer of hope.

Kate

Written by
Eucalyptus22 profile image
Eucalyptus22
To view profiles and participate in discussions please or .
Read more about...
1 Reply
AussieNeil profile image
AussieNeilAdministrator

Thanks Kate, We could do with some hope!

NewAtlas provide a thorough update on this promising UDCA research here:-

New COVID treatment found in old liver drug derived from bear bile

newatlas.com/health-wellbei...

The Conversation covers it here:- A liver disease drug could be repurposed to protect against COVID – new research

theconversation.com/a-liver...

This looks rather promising and hopefully in the reasonably near term. I've take the liberty of extending your title, so that the research is clearly identified, plus I've assigned a topic to your post.

Neil

You may also like...

Study shedding more light on how Ibrutinib works

these drugs with another drug. In summary in a culture setting outside the body these researchers...

Cinetidine & Loratadine ect

basic research and found that several drugs in this class including Tagamet are being researched as...

URGENT alert Re Houmous products

could be life threatening. Here is the list:...

Paxlovid in U.S. News

reports: https://www.cnn.com/2022/10/12/health/paxlovid-drug-interactions/index.html...

Factors affecting pricing for Ibrutinib and Venetoclax

gaming of the US Patent system by Big Pharma makes critical drugs very expensive....